Session Information
-
ACLC 2018
IASLC Asia Conference on Lung Cancer 2018
Access Abstracts and Powerpoint Slides to select presentations that took place during the IASLC Asia Conference on Lung Cancer 2018 in Guangzhou, China from November 8 - 10, 2018. This package is available for no charge to active IASLC Members.
Presentation Date(s):- November 8 - 10, 2018
- Total Presentations: 137
November 7 Wed
Nov 7 Thursday
November 8 Thu
Nov 8 Friday
November 9 Fri
Nov 9 Saturday
November 10 Sat
Nov 10
-
+
Poster Session
- 00:00 - 00:00
- 11/07/2018
- Location: Poster Hall
- Type: Poster Session
- Track:
-
+
- Abstract
Loading... -
- Abstract
Loading... -
+
- Abstract
Loading... -
+
- Abstract
Loading... -
+
- Abstract
Loading... -
+
- Abstract
Loading... -
+
- Abstract
Loading... -
+
- Abstract
Loading... -
+
P015 - Motion Management Without Fiducial Tracking Using Cyberknife SBRT
00:00 - 00:00 | Presenter: G. Lohith, S. Varun Kumar, S. Shwetha, P. Anuradha
- Abstract
Loading... -
+
P016 - The Optimal ALK inhibitor in Advanced ALK-Positive NSCLC Patients: An Indirect Comparison Between Brigatinib and Alectinib
00:00 - 00:00 | Presenter: H Zhou
- Abstract
Loading... -
+
- Abstract
Loading... -
+
P018 - Afatinib Named Patient Use Program in Advanced NSCLC with Progression on Prior Therapy: Experience from Asian Centers
00:00 - 00:00 | Presenter: G. Chang, D.C. Lam, C. Tsai, Y. Chen, J. Shih, S. Aggarwal, S. Wang, S. Kim, Y. Kim, I. Wahid, R. Li, W. Lim, V. Sriuranpong, T.T. Chan, J.C. Yang, C. Yu, W. Liao, C. Ho, R.M. Lorence, P. Carriere, C. Raabe, A. Cseh, K. Park
- Abstract
Loading... -
+
P020 - Characterization of Met Exon 14 Skipping and Association with Clinical Outcomes of Crizotinib in Chinese Lung Cancers
00:00 - 00:00 | Presenter: H. Yang, C. Zhou, Y. Su, Z. Zhou, P. Chen, M. Yang, C. Li, W. Guo, W. Zhao, K. Lu, J. Yin, J. Chen, Z. Li, X. Yu, X. Xu, J. Xiang, T. Zhang, B. Li, L. Zhang, H. Liu, N. Yang
- Abstract
Loading... -
+
- Abstract
Loading... -
+
- Abstract
Loading... -
+
P023 - Factors associated with administration of subsequent cytotoxic chemotherapy after nivolumab in patients with advanced NSCLC
00:00 - 00:00 | Presenter: H. Jo, H. Horinouchi, R. Higashiyama, N. Tamura, S. Yagishita, Y. Matsumoto, S. Murakami, Y. Goto, S. Kanda, Y. Fujiwara, N. Yamamoto, Y. Ohe
- Abstract
Loading... -
+
- Abstract
Loading... -
+
P025 - Which Is the Optimal Immunotherapy for Advanced Non-Squamous Non-Small-Cell Lung Cancer in Combination with Chemotherapy?
00:00 - 00:00 | Presenter: H Zhou
- Abstract
Loading... -
+
- Abstract
Loading... -
+
- Abstract
Loading... -
+
- Abstract
Loading... -
+
- Abstract
Loading... -
+
P032 - Integrin Subunit Alpha 5: Potential Prognostic Biomarker in Lung Adenocarcinoma
00:00 - 00:00 | Presenter: J.H. Hong
- Abstract
Loading... -
+
- Abstract
Loading... -
+
P034 - A Case of Stage IIIA Thymoma Underwent Thymectomy with the Subxiphoid Approach
00:00 - 00:00 | Presenter: B. Aramini, J. Gening, J. Fan
- Abstract
Loading... -
+
- Abstract
Loading... -
- Abstract
Loading... -
+
- Abstract
Loading... -
+
- Abstract
Loading... -
+
- Abstract
Loading... -
+
- Abstract
Loading... -
+
- Abstract
Loading... -
+
- Abstract
Loading... -
+
- Abstract
Loading... -
+
- Abstract
Loading... -
+
- Abstract
Loading... -
+
- Abstract
Loading... -
+
P050 - Long-Term Survival of Stage IIIA-N2 NSCLC Patients with Interstitial Lung Diseases
00:00 - 00:00 | Presenter: J. Watanabe, H. Horinouchi, Y. Shinno, S. Murakami, Y. Goto, S. Kanda, Y. Fujiwara, N. Yamamoto, Y. Nakamura, S. Watanabe, Y. Ohe
- Abstract
Loading... -
+
- Abstract
Loading... -
+
- Abstract
Loading... -
+
- Abstract
Loading... -
+
- Abstract
Loading... -
+
P057 - Pembrolizumab +
00:00 - 00:00 | Presenter: K.F. Ang, R.J. Villafuerte, E. Regala
- Abstract
Loading... -
+
P058 - Effects of Neoadjuvant Chemotherapy on the Expression
00:00 - 00:00 | Presenter: W. Sun
- Abstract
Loading... -
+
- Abstract
Loading... -
+
- Abstract
Loading... -
+
- Abstract
Loading... -
+
- Abstract
Loading... -
+
- Abstract
Loading... -
+
- Abstract
Loading... -
+
- Abstract
Loading... -
+
- Abstract
Loading... -
+
- Abstract
Loading... -
+
- Abstract
Loading... -
+
- Abstract
Loading... -
+
- Abstract
Loading... -
+
P080 - Efficacy and Safety of Docetaxel Plus Ramucirumab: A Consecutive Analysis of 68 Patients with Advanced NSCLC
00:00 - 00:00 | Presenter: S. Yokota, H. Horinouchi, S. Kanda, Y. Fujiwara, S. Murakami, Y. Goto, Y. Matsumoto, R. Morita
- Abstract
Loading... -
+
- Abstract
Loading... -
+
- Abstract
Loading... -
+
P083 - Efficacy of EGFR-TKIs in Patients Harboring EGFR Mutations with Non-Adenocartinoma Histology
00:00 - 00:00 | Presenter: O Yuko
- Abstract
Loading... -
- Abstract
Loading... -
+
P086 - Toward the Standardization of Bioinformatics Methods for the Accurate Assessment of Tumor Mutational Burden (TMB)
00:00 - 00:00 | Presenter: H. Chang, S. Srinivasan, A. Sasson, R. Golhar, D. Greenawalt, S. Kirov, J. Szustakowski
- Abstract
Loading... -
+
- Abstract
Loading... -
+
P088 - Distribution of Different HER2 Mutations
00:00 - 00:00 | Presenter: W Wang
- Abstract
Loading... -
+
- Abstract
Loading... -
+
- Abstract
Loading... -
+
- Abstract
Loading... -
+
- Abstract
Loading... -
+
- Abstract
Loading... -
+
- Abstract
Loading... -
+
- Abstract
Loading... -
+
- Abstract
Loading... -
+
- Abstract
Loading... -
+
- Abstract
Loading... -
+
- Abstract
Loading... -
+
- Abstract
Loading... -
+
- Abstract
Loading... -
+
- Abstract
Loading... -
+
- Abstract
Loading... -
+
- Abstract
Loading... -
+
- Abstract
Loading... -
+
- Abstract
Loading... -
+
P113 - Icotinib Alone or with Radio Therapy Inpatients with EGFR Mutations Non-Small Cell Lung Cancer Who Develop Brain Metastases
00:00 - 00:00 | Presenter: Y. Xin
- Abstract
Loading... -
- Abstract
Loading... -
+
- Abstract
Loading... -
+
- Abstract
Loading... -
+
- Abstract
Loading... -
+
- Abstract
Loading... -
+
P120 - How to Become Exsomes As Messengers and Sentinels to Influence Lung Cancer Growing?
00:00 - 00:00 | Presenter: Z. Yu
- Abstract
Loading... -
+
- Abstract
Loading...
-
+
Best abstracts selected from submissions 1
- 10:55 - 11:30
- 11/08/2018
- Location: Crystal Ballroom
- Type: Oral Session
- Track:
-
+
- Abstract
Loading... -
+
- Abstract
Loading...
-
+
Best abstracts selected from submissions 2
- 16:20 - 17:00
- 11/08/2018
- Location: Jade Ballroom
- Type: Oral Session
- Track:
-
+
OA03 - Afatinib Followed by Osimertinib in Real-World Patients with EGFR Mutation-Positive Advanced NSCLC: The Giotag Study
06:20 - 06:30 | Presenter: M.J. Hochmair, A. Morabito, D. Hao, C. Yang, R. Soo, J.C. Yang, R. Gucalp, B. Halmos, A. Golembesky, A. M, T. Cufer
- Abstract
Loading... -
+
OA04 - Factors Influencing the Non-Administration of Chemotherapies in Patients Who Progressed After
06:30 - 06:40 | Presenter: T. Mizuno, H. Horinouchi, S. Watanabe, J. Sato, R. Morita, Y. Matsumoto, S. Murakami, Y. Goto, S. Kanda, Y. Fujiwara, N. Yamamoto, Y. Ohe
- Abstract
Loading...
-
+
Best abstracts selected from submissions 3
- 16:20 - 17:00
- 11/08/2018
- Location: Crystal Ballroom 1
- Type: Oral Session
- Track:
-
+
OA05 - Tumor Mutational Burden Standardization Initiative: Establish a Consistent Methodology for TMB Measurement in Clinical Samples
06:20 - 06:30 | Presenter: F Yan
- Abstract
Loading... -
+
- Abstract
Loading...
-
+
Parallel Session 1 - Biomarker detecting for lung cancer: new technique and new opinion
- 16:20 - 17:00
- 11/08/2018
- Location: Jade Ballroom
- Type: Oral Session
- Track:
-
+
What is a trustworthy biomarker?
04:25 - 04:50 | Presenter: C Manegold
- Abstract
No abstract available for this presentation
-
+
Standardization of molecular testing in China
04:50 - 05:15 | Presenter: X Zhang
- Abstract
No abstract available for this presentation
-
+
Discussant - Sequencing or Combination?
06:40 - 07:00 | Presenter: J Hu
- Abstract
No abstract available for this presentation
-
+
Parallel Session 2 - Brain metastases and Leptomeningeal metastasis
- 16:20 - 17:00
- 11/08/2018
- Location: Crystall Ballroom 1
- Type: Oral Session
- Track:
-
+
Diagnosis and management of leptomeningeal metastasis
05:15 - 05:40 | Presenter: J Yang
- Abstract
No abstract available for this presentation
-
+
Optimal radiotherapy for CNS metastasis in patients with a driver oncogene
20:25 - 20:50 | Presenter: Y Lu
- Abstract
No abstract available for this presentation
-
+
Can this drug penetrate the brain?
20:50 - 21:15 | Presenter: F Kong
- Abstract
No abstract available for this presentation
-
+
Parallel Session 3 - Tobacco control, Staging and cancer prevention in Asia
- 16:20 - 17:00
- 11/08/2018
- Location: Crystall Ballroom 3
- Type: Oral Session
- Track:
-
+
Tobacco control in China
04:00 - 04:20 | Presenter: X Zhi
- Abstract
No abstract available for this presentation
-
+
Plenary Session - Past, Present and Future of Targeted Therapy in NSCLC
- 16:20 - 17:00
- 11/08/2018
- Location: Crystal Ballroom
- Type: Oral Session
- Track:
-
+
Optimal sequence of EGFR TKI
08:15 - 08:40 | Presenter: T Mok
- Abstract
No abstract available for this presentation
-
+
Clinical application of ctDNA in management of oncogenic driven lung cancer
09:05 - 09:30 | Presenter: S Lu
- Abstract
No abstract available for this presentation
-
+
Optimal sequence of ALK TKI
08:40 - 09:05 | Presenter: I Ou
- Abstract
No abstract available for this presentation
-
+
Best abstracts selected from submissions 4
- 10:50 - 11:30
- 11/09/2018
- Location: Crystal Ballroom
- Type: Oral Session
- Track:
-
+
- Abstract
Loading... -
+
- Abstract
Loading...
-
+
Best abstracts selected from submissions 5
- 16:20 - 17:00
- 11/09/2018
- Location: Crystal Ballroom 1
- Type: Oral Session
- Track:
-
+
OA09 - Preliminary Clinical Activity of Repotrectinib (TPX-0005) in Advanced ROS1 Fusion-Positive Non-Small Cell Lung Cancer
22:20 - 22:30 | Presenter: S. Ou, B.C. Cho, D. Kim, A. Drilon, J. Lee, J. Lin, V. Zhu, M. Ahn, D.R. Camidge, S. Shanna Stopatschinskaja, J. Liu, J. Cui, D. Hyman, R. Doebele, A. Shaw
- Abstract
Loading... -
+
OA10 - CheckMate 078: Patient-Reported Outcomes (PROs) With Nivolumab vs Docetaxel in Advanced Non-Small Cell Lung Cancer (NSCLC)
06:30 - 06:40 | Presenter: Y. Wu, J. Chang, L. Zhang, H. Tu, L. Wu, J. Feng, S. Lu, C. Zhou, J. Wang, T. Mok, F. Taylor, B. Mossman, J. Penrod, R. Lawrance, S. Blum, P.F. Wang, Y. Cheng
- Abstract
Loading...